Zhende Medical Co (SHSE:603301) Accounts Payable: ¥487 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603301 Zhende Medical Co Ltd SHSE:603301
53 GF Score
Price ¥81.24
GF Value ¥26.63
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Zhende Medical Co Accounts Payable?

Zhende Medical Co SHSE:603301 -3.46% 53 Accounts Payable is ¥487 Mil as of Jun. 2026. GuruFocus rates SHSE:603301 with a GF Score™ of 53/100 and a GF Value™ of ¥26.63 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Zhende Medical Co's Accounts Payable for the quarter that ended in Jun. 2026 was ¥487 Mil.

Zhende Medical Co's quarterly Accounts Payable declined from Dec. 2025 (¥573 Mil) to Mar. 2026 (¥447 Mil) but then increased from Mar. 2026 (¥447 Mil) to Jun. 2026 (¥487 Mil).

Zhende Medical Co's annual Accounts Payable increased from Dec. 2023 (¥413 Mil) to Dec. 2024 (¥484 Mil) and increased from Dec. 2024 (¥484 Mil) to Dec. 2025 (¥573 Mil).

Zhende Medical Co Accounts Payable Related Terms

Zhende Medical Co Accounts Payable Historical Data

* Premium members only.

The historical data trend for Zhende Medical Co's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhende Medical Co Accounts Payable Chart

Zhende Medical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 624.31 702.70 412.55 484.22 573.03

Zhende Medical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 426.66 409.26 573.03 447.45 486.91
SHSE:603301
53GF Score
Zhende Medical Co Ltd SHSE:603301
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhende Medical Co Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of ¥487 Mil mean?
Zhende Medical Co (SHSE:603301) has a Accounts Payable of ¥487 Mil as of Jun. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Zhende Medical Co and its competitors.
Is Zhende Medical Co's Accounts Payable too high?
Zhende Medical Co's current Accounts Payable is ¥487 Mil. Overall, Zhende Medical Co has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Zhende Medical Co's Accounts Payable compare to ISRG and BDX?
Zhende Medical Co's Accounts Payable of ¥487 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Devices & Instruments company?
A good Accounts Payable depends on the Medical Devices & Instruments industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Zhende Medical Co and its competitors. Zhende Medical Co's current Accounts Payable is ¥487 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhende Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhende Medical Co (SHSE:603301) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥26.63, compared to a current price of ¥81.24 — trading 205.1% above its estimated fair value. The current Accounts Payable is ¥487 Mil. Zhende Medical Co's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Zhende Medical Co (SHSE:603301), the current Accounts Payable is ¥487 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhende Medical Co (SHSE:603301) Overvalued in 2026?

Based on GuruFocus' analysis, Zhende Medical Co stock appears to be overvalued. The current stock price of ¥81.24 is trading 205.1% above its estimated GF Value™ of ¥26.63. GuruFocus considers Zhende Medical Co to be Significantly Overvalued.

Key valuation signals for SHSE:603301:

  • Accounts Payable: ¥487 Mil
  • GF Value™: ¥26.63 vs. price of ¥81.24 (205.1% above fair value)
  • GF Score™: 53/100 with 4 warning signs

No single metric tells the full story. See the SHSE:603301 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zhende Medical Co Business Description

Address No. 55 Xiangji Road, Gaobu Street, Yuecheng District, Zhejiang Province, Shaoxing City, CHN, 312035
Zhende Medical Co Ltd operates as a supplier of medical care and protection in China. The company is engaged in the production and sales of medical dressings. Its product categories are basic medical dressings, operating room sensory control, pressure therapy and fixation, stoma and chronic wounds, Isolation protection, and personal protection.
53GF Score

Get the complete analysis for SHSE:603301

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥81.24
Price
¥26.63
GF Value